1. World Health Organization. Global tuberculosis control: WHO report 2011. 2011. Geneva: WHO;9–27.
2. Kim HJ. Current status of tuberculosis in Korea. Korean J Med. 2012. 82:257–262.
Article
3. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep. 2000. 49(RR-6):1–51.
4. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med. 2007. 146:340–354.
Article
5. Pai M, Zwerling A, Menzies D. Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med. 2008. 149:177–184.
Article
6. Mazurek GH, Jereb J, Lobue P, Iademarco MF, Metchock B, Vernon A. Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention (CDC). Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Morb Mortal Wkly Rep. 2005. 54:49–55.
7. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and non-tuberculous mycobacteria? Int J Tuberc Lung Dis. 2006. 10:1192–1204.
8. Lewinsohn DA, Lobato MN, Jereb JA. Interferon-γ release assays: new diagnostic tests for
Mycobacterium tuberculosis infection, and their use in children. Curr Opin Pediatr. 2010. 22:71–76.
Article
9. Canadian Tuberculosis Committee (CTC). Recommendations on interferon gamma release assays for the diagnostic latent tuberculosis infection-2010 update. Can Commun Dis Rep. 2010. 36(ACS-5):1–21.
10. Starke JR. New concepts in childhood tuberculosis. Curr Opin Pediatr. 2007. 19:306–313.
Article
11. Denkinger CM, Dheda K, Pai M. Guidelines on interferon-γ release assays for tuberculosis infection: concordance, discordance or confusion? Clin Microbiol Infect. 2011. 17:806–814.
Article
12. Ling DI, Zwerling AA, Steingart KR, Pai M. Immune-based diagnostics for TB in children: what is the evidence? Paediatr Respir Rev. 2011. 12:9–15.
Article
13. Machingaidze S, Wiysonge CS, Gonzalez-Angulo Y, Hatherill M, Moyo S, Hanekom W, et al. The utility of an interferon gamma release assay for diagnosis of latent tuberculosis infection and disease in children: a systematic review and meta-analysis. Pediatr Infect Dis J. 2011. 30:694–700.
Article
14. Bouros D, Zeros G, Panaretos C, Vassilatos C, Siafakas N. Palpation vs pen method for the measurement of skin tuberculin reaction (Mantoux test). Chest. 1991. 99:416–419.
Article
15. Cellestis. QuantiFERON®-TB Gold (in-tube method) package insert, document No. US05990301E, January 2009. Accessed 12 September 2012. Available at:
http://www.cellestis.com.
16. National Collaborating Centre for Chronic Conditions. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. 2006. London: Royal College of Physicians;105–114.
17. Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Obihara CC, Starke JJ, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis. 2004. 8:392–402.
18. Marais BJ, Donald PR. Schaar HS, Zulma AI, editors. The natural history of tuberculosis infection and disease in children. Tuberculosis: a comprehensive clinical reference. 2009. Philadelphia: Elsevier Inc.;133–145.
Article
19. Lighter J, Rigaud M, Eduardo R, Peng C, Pollack H. Latent tuberculosis diagnosis in children by using the QuantiFERON-TB Gold In-Tube test. Pediatrics. 2009. 123:30–37.
Article
20. O'Neal S, Hedberg K, Markum A, Schafer S. Discordant tuberculin skin and interferon-gamma tests during contact investigations: a dilemma for tuberculosis controllers. Int J Tuberc Lung Dis. 2009. 13:662–664.
21. Herrera V, Perry S, Parsonnet J, Banaei N. Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection. Clin Infect Dis. 2011. 52:1031–1037.
Article
22. Chun JK, Kim CK, Kim HS, Jung GY, Lee TJ, Kim KH, et al. The role of a whole blood interferon-assay for the detection of latent tuberculosis infection in Bacille Calmette-Guerin vaccinated children. Diagn Microbiol Infect Dis. 2008. 62:389–394.
Article
23. Sung JY, Kim JH, Yang MA, Kim SH, Eun BW, Lee J, et al. Usefulness of interferon-γ measurement following stimulation of tuberculosis-specific antigens for diagnosis of latent tuberculosis infection in children exposed to pulmonary tuberculosis. Korean J Pediatr Infect Dis. 2008. 15:50–57.
Article
24. Chun JK, Kim CK, Kim HS, Jung GY, Linton JA, Kim KH, et al. Comparison of a whole blood Interferon-gamma assay and A tuberculin skin test for detecting latent tuberculosis infection in children. Korean J Pediatr. 2008. 51:971–976.
Article
25. Kim YJ, Lee JS. Comparison of Interferon-gamma assays with the tuberculin skin test in children. Pediatr Allergy Respir Dis. 2010. 20:10–16.
26. Soon EG, Lim BK, Kim HM, Namgoong MK, Cha BH, Uh Y, et al. A tapping the usefulness of whole blood interferon-gamma assay for diagnosing tuberculosis infection in children. Tuberc Respir Dis. 2010. 68:280–285.
Article
27. Lee HW, Park HY, Ahn YM, Sohn KC. Clinical significance of interferon gamma release assay for diagnosis of tuberculosis in children. Korean J Pediatr Infect Dis. 2010. 17:137–147.
Article
28. Lee YJ, Chun P, We JH, Park SE. Accuracy of an interferon-gamma release assay to detect active tuberculosis in children: a pilot study. Korean J Pediatr Infect Dis. 2011. 18:48–53.
Article
29. Park YM, Chung S, Yoo KH. Relationship between asthma and latent tuberculosis infection in children. Korean J Asthma Allergy Clin Immunol. 2012. 32:101–106.